Avances recientes en la meningoencefalitis amebiana primaria: revisión exhaustiva de compuestos terapéuticos y perspectivas de vacunas
Recent advances in primary amoebic meningoencephalitis: a comprehensive review of therapeutic compounds and vaccine prospects
##plugins.themes.bootstrap3.article.sidebar##
PDF
FLIP
##plugins.themes.bootstrap3.article.main##
Este artículo de revisión explora los últimos avances en el estudio de la meningoencefalitis amebiana primaria. Se destaca la importancia de las vacunas como posible medida preventiva innovadora que podría revolucionar la lucha contra la meningoencefalitis amebiana primaria y su eliminación. Además, se hace hincapié en la importancia de las aplicaciones prospectivas de los fitoquímicos procedentes de distintas fuentes naturales. Esta revisión ofrece un amplio panorama de las fronteras en el tratamiento y la prevención de la meningoencefalitis amebiana primaria, integrando las investigaciones más recientes con las posibles direcciones futuras.
Descargas
##plugins.themes.bootstrap3.article.details##
Visvesvara GS. Infections with free-living amebae. Handb Clin Neurol. 2013;114:153-68. doi: 10.1016/B978-0-444-53490-3.00010-8
Güémez A, García E. Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments. Biomolecules. 2021;11(9):1320. doi: 10.3390/biom11091320
Centers for Disease Control and Prevention. Prevention and Control of Naegleria fowleri in Recreational Water. Atlanta: CDC; 2023.
Lopez C, Budge P, Chen J, Bilyeu S, Mirza A, Custodio H, et al. Primary amebic meningoencephalitis: a case report and literature review. Pediatr Emerg Care. 2012;28(3):272-6. doi: 10.1097/PEC.0b013e3182495589
Kim JH, Lee SH, Sohn HJ, Lee J, Chwae YJ, Park S, et al. The immune response induced by DNA vaccine expressing nfa1 gene against Naegleria fowleri. Parasitol Res. 2012;111(6):2377-84. doi: 10.1007/s00436-012-3093-5
Siddiqui R, Ali IKM, Cope JR, Khan NA. Biology and pathogenesis of Naegleria fowleri. Acta Trop. 2016;164:375-394. doi: 10.1016/j.actatropica.2016.09.009.
Pugh JJ, Levy RA. Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments. ACS Chem Neurosci. 2016;7(9):1178-9. doi: 10.1021/acschemneuro.6b00232
Chalmers RM. Chapter Twenty - Naegleria. In: Percival SL, Yates MV, Williams DW, Chalmers RM, Gray NF, editors. Microbiology of Waterborne Diseases (Second Edition) [Internet]. London: Academic Press; 2014 [cited 2024 Mar 23]. p. 407–16. Available from: https://www.sciencedirect.com/science/article/pii/B9780124158467000202
Prevention CfDCa. Naegleria fowleri - Primary amebic meningoencephalitis (PAM) - Amebic encephalitis [Internet]. 2021 [cited 2024 Mar 3]. Available from: https://www.cdc.gov/parasites/naegleria/naegleria-fowleri-media.html.
Dereeper A, Allouch N, Guerlais V, Garnier M, Ma L, De Jonckheere JF, et al. Naegleria genus pangenome reveals new structural and functional insights into the versatility of these free-living amoebae. Front Microbiol. 2023;13:1056418. doi: 10.3389/fmicb.2022.1056418
Mungroo MR, Anwar A, Khan NA, Siddiqui R. Brain-eating Amoebae Infection: Challenges and Opportunities in Chemotherapy. Mini Rev Med Chem. 2019;19(12):980-87. doi: 10.2174/1389557519666190313161854
Fillatre P, Crabol Y, Morand P, Piroth L, Honnorat J, Stahl J, et al. Infectious encephalitis: Management without etiological diagnosis 48 hours after onset. Med Mal Infect. 2017;47(3):236-51. doi: 10.1016/j.medmal.2017.02.004
Siddiqui R, Khan NA. Primary amoebic meningoencephalitis caused by Naegleria fowleri: an old enemy presenting new challenges. PLoS Negl Trop Dis. 2014;8(8):e3017. doi: 10.1371/journal.pntd.0003017
Schultz DR, Harrington WJ Jr. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum. 2003;32(6):345-69. doi: 10.1053/sarh.2003.50005
Cummings BS, McHowat J, Schnellmann RG. Phospholipase A2s in cell injury and death. Journal of pharmacology and experimental therapeutics. 2000;294(3):793-9.
Betanzos A, Bañuelos C, Orozco E. Host Invasion by Pathogenic Amoebae: Epithelial Disruption by Parasite Proteins. Genes (Basel). 2019;10(8):618. doi: 10.3390/genes10080618
Cope JR, Ali IK. Primary Amebic Meningoencephalitis: What Have We Learned in the Last 5 Years? Curr Infect Dis Rep. 2016;18(10):31. doi: 10.1007/s11908-016-0539-4
Jahangeer M, Mahmood Z, Munir N, Waraich UeA, Tahir IM, Akram M, et al. Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review.Clin Exp Pharmacol Physiol. 2020;47(2):199-212. doi: 10.1111/1440-1681.13192
Kofman A, Guarner J. Infections Caused by Free-Living Amoebae. J Clin Microbiol. 2022;60(1):e0022821. doi: 10.1128/JCM.00228-21
Deresinski S. Amebic Meningoencephalitis. Infectious Disease Alert. 2021;40(11).
Centers for Disease Control and Prevention. Primary Amebic Meningoencephalitis (PAM) - Diagnosis & Treatment. Atlanta: CDC; 2021.
Russell AC, Kyle DE. Differential growth rates and in vitro drug susceptibility to currently used drugs for multiple isolates of Naegleria fowleri.Microbiol Spectr. 2022;10(1):e0189921. doi: 10.1128/spectrum.01899-21
Russell AC, Bush P, Grigorean G, Kyle DE. Characterization of the extracellular vesicles, ultrastructural morphology, and intercellular interactions of multiple clinical isolates of the brain-eating amoeba, Naegleria fowleri. Front Microbiol. 2023;14:1264348. doi: 10.3389/fmicb.2023.1264348
Cope JR, Conrad DA, Cohen N, Cotilla M, DaSilva A, Jackson J, et al. Use of the novel therapeutic agent miltefosine for the treatment of primary amebic meningoencephalitis: report of 1 fatal and 1 surviving case. Clin Infect Dis. 2016;62(6):774-6. doi: 10.1093/cid/civ1021
Singh P, Kochhar R, Vashishta RK, Khandelwal N, Prabhakar S, Mohindra S, Singhi P. Amebic meningoencephalitis: spectrum of imaging findings. AJNR Am J Neuroradiol. 2006;27(6):1217-21.
Atanasov AG, Zotchev SB, Dirsch VM; International Natural Product Sciences Taskforce; Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-16. doi: 10.1038/s41573-020-00114-z
Arberas-Jiménez I, Nocchi N, Chao-Pellicer J, Sifaoui I, Soares AR, Díaz-Marrero AR, et al. Chamigrane-Type Sesquiterpenes from Laurencia dendroidea as Lead Compounds against Naegleria fowleri. Mar Drugs. 2023;21(4):224. doi: 10.3390/md21040224
Morales-Ubaldo AL, Rivero-Perez N, Valladares-Carranza B, Madariaga-Navarrete A, Higuera-Piedrahita RI, Delgadillo-Ruiz L, et al. Phytochemical compounds and pharmacological properties of larrea tridentata. Molecules. 2022;27(17):5393. doi: 10.3390/molecules27175393
Basharat Z, Zaib S, Yasmin A. Computational study of some amoebicidal phytochemicals against heat shock protein of Naegleria fowleri. Gene Rep. 2017;6:158-62. doi: 10.1016/j.genrep.2016.09.003
Lê HG, Kang JM, Võ TC, Na BK. Kaempferol induces programmed cell death in Naegleria fowleri. Phytomedicine. 2023;119:154994. doi: 10.1016/j.phymed.2023.154994
Arberas-Jiménez I, Rizo-Liendo A, Nocchi N, Sifaoui I, Chao-Pellicer J, Souto ML, et al. Sesquiterpene lactones as potential therapeutic agents against Naegleria fowleri. Biomed Pharmacother. 2022;147:112694. doi: 10.1016/j.biopha.2022.112694
Arberas-Jiménez I, García-Davis S, Rizo-Liendo A, Sifaoui I, Morales EQ, Piñero JE, et al. Cyclolauranes as plausible chemical scaffold against Naegleria fowleri. Biomed Pharmacother. 2022;149:112816. doi: 10.1016/j.biopha.2022.112816
Daniel N, Ferdinand F, Aditya PA. In silico targeting CYP51 of Naegleria fowleri using bioactive compounds from Indonesian plants. J Pharm Pharmacogn Res. 2023;11(5):841-62. doi: 10.56499/jppres23.1693_11.5.841
Cabanes PA, Wallet F, Pringuez E, Pernin P. Assessing the risk of primary amoebic meningoencephalitis from swimming in the presence of environmental Naegleria fowleri. Appl Environ Microbiol. 2001;67(7):2927-31. doi: 10.1128/AEM.67.7.2927-2931.2001
Bureau UC. Statistical Abstract of the United States. 2009.
Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments. Nat Rev Immunol. 2021;21(2):83-100. doi: 10.1038/s41577-020-00479-7
Lee YJ, Kim JH, Sohn HJ, Lee J, Jung SY, Chwae YJ, et al. Effects of immunization with the rNfa1 protein on experimental Naegleria fowleri-PAM mice. Parasite Immunol. 2011;33(7):382-9. doi: 10.1111/j.1365-3024.2011.01296.x
Kang SY, Song KJ, Jeong SR, Kim JH, Park S, Kim K, et al. Role of the Nfa1 protein in pathogenic Naegleria fowleri cocultured with CHO target cells. Clin Diagn Lab Immunol. 2005;12(7):873-6. doi: 10.1128/CDLI.12.7.873-876.2005
Gutiérrez-Sánchez M, Carrasco-Yépez MM, Correa-Basurto J, Ramírez-Salinas GL, Rojas-Hernández S. Two MP2CL5 Antigen Vaccines from Naegleria fowleri Stimulate the Immune Response against Meningitis in the BALB/c Model. Infect Immun. 2023;91(7):e0018123. doi: 10.1128/iai.00181-23
Réveiller FL, Suh SJ, Sullivan K, Cabanes PA, Marciano-Cabral F. Isolation of a unique membrane protein from Naegleria fowleri. J Eukaryot Microbiol. 2001;48(6):676-82. doi: 10.1111/j.1550-7408.2001.tb00208.x
Carrasco-Yepez M, Campos-Rodriguez R, Lopez-Reyes I, Bonilla-Lemus P, Rodriguez-Cortes AY, Contis-Montes de Oca A, et al. Intranasal coadministration of Cholera toxin with amoeba lysates modulates the secretion of IgA and IgG antibodies, production of cytokines and expression of pIgR in the nasal cavity of mice in the model of Naegleria fowleri meningoencephalitis. Exp Parasitol. 2014;145 Suppl:S84-92. doi: 10.1016/j.exppara.2014.04.002
Lai R, Ogunsola AF, Rakib T, Behar SM. Key advances in vaccine development for tuberculosis-success and challenges. NPJ Vaccines. 2023;8(1):158. doi: 10.1038/s41541-023-00750-7
Casadei E, Salinas I. Comparative models for human nasal infections and immunity. Dev Comp Immunol. 2019;92:212-222. doi: 10.1016/j.dci.2018.11.022
Rojas-Ortega DA, Rojas-Hernández S, Sánchez-Mendoza ME, Gómez-López M, Sánchez-Camacho JV, Rosales-Cruz E, et al. Role of FcγRIII in the nasal cavity of BALB/c mice in the primary amebic meningoencephalitis protection model. Parasitol Res. 2023;122(5):1087-1105. doi: 10.1007/s00436-023-07810-w
Nicolson GL. The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. Biochim Biophys Acta. 2014;1838(6):1451-66. doi: 10.1016/j.bbamem.2013.10.019
Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50(1):1-26. doi: 10.1111/j.1574-695X.2007.00232.x
